CTOs on the Move

Fluence Analytics

www.fluenceanalytics.com

 
Fluence Analytics is a leader in continuous analytics and process control solutions for the polymer and biopharmaceutical industries. The company offers two product lines, ACOMP and ARGEN. ACOMP is a polymer smart manufacturing system that generates ne...
  • Number of Employees: 25-100
  • Annual Revenue: $1-10 Million

Executives

Name Title Contact Details

Similar Companies

Nomad Health

Nomad Health is the first digital marketplace for healthcare jobs, efficiently connecting quality clinicians with rewarding career opportunities and taking the busywork out of finding clinical work. We are a well-funded Series C startup backed by First Round Capital, RRE Ventures, .406 Ventures, Polaris Partners, Icon Ventures, and Kevin Ryan (founder of MongoDB, Zola, Gilt, and DoubleClick). The U.S. healthcare system is experiencing a staffing crisis. Employers spend $20 billion per year recruiting clinicians to provide care for patients around the country. Nomad replaces antiquated staffing agencies with modern technology to efficiently source, qualify, and hire medical talent on demand. Clinicians find better jobs with higher pay. Employers fill roles faster with higher quality care. Nomad is a fast growing team of technologists, creators, and industry experts passionate about modernizing healthcare staffing so doctors and nurses can get back to the work they do best: caring for others.

Toxikon Corporation

Toxikon Corporation is a Bedford, MA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

23andMe

23andMe is one of the leading companies in the Healthcare, Pharmaceuticals, and Biotech sector.

Parker HealthcareIT

Parker HealthcareIT is a Seattle, WA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Framingham Heart Study

Since our beginning in 1948, the Framingham Heart Study, under the direction of the National Heart, Lung and Blood Institute (NHLBI), formerly known as the National Heart Institute, has been committed to identifying the common factors or characteristics that contribute to cardiovascular disease (CVD). We have followed CVD development over a long period of time in three generations of participants.